2020
DOI: 10.7324/japs.2021.110209
|View full text |Cite
|
Sign up to set email alerts
|

Validation of a high-performance liquid chromatographic method for the assay and dissolution of captopril in mucoadhesive tablet formulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…It's mainly used for the treatment of arterial hypertension, heart failure [12][13][14], diabetic nephropathy [15], and some other diseases resulting from heart failure [16]; it's widely used by geriatric patients who suffer from these diseases [17]. Captopril may cause side effects such as coughing [18]. Captopril has been quantified by more than one analytical method, including spectrophotometry [19][20][21][22], flow injection methods [23][24][25][26][27][28], RP-HPLC [29,30], and HPLC [31][32][33].…”
Section: Introductionmentioning
confidence: 99%
“…It's mainly used for the treatment of arterial hypertension, heart failure [12][13][14], diabetic nephropathy [15], and some other diseases resulting from heart failure [16]; it's widely used by geriatric patients who suffer from these diseases [17]. Captopril may cause side effects such as coughing [18]. Captopril has been quantified by more than one analytical method, including spectrophotometry [19][20][21][22], flow injection methods [23][24][25][26][27][28], RP-HPLC [29,30], and HPLC [31][32][33].…”
Section: Introductionmentioning
confidence: 99%